Literature DB >> 15485774

Axonal responses to cellularly delivered NT-4/5 after spinal cord injury.

Armin Blesch1, Hong Yang, Norbert Weidner, An Hoang, Deborah Otero.   

Abstract

Neurotrophic factors delivered to the injured spinal cord have been shown to enhance axonal growth, prevent neuronal degeneration and partially improve sensorimotor function. The present study examined the effects of NT-4/5 on growth of spinal and supraspinal axons, glia, and functional outcome after spinal cord injury. Adult Fischer 344 rats received spinal cord dorsal hemisections or complete transections at the midthoracic level. Fibroblasts modified to secrete NT-4/5 or green fluorescent protein as controls were immediately grafted to the lesion site. Axonal growth responses were determined between 3 and 6 months postinjury by retrograde and anterograde tracing and immunohistochemistry. Motor axons, coerulospinal, reticulospinal, and propriospinal axons responded to NT-4/5 delivery after thoracic spinal cord injury with significantly increased axonal penetration into NT-4/5 secreting grafts compared to GFP-expressing control grafts. Axonal growth beyond NT-4/5-producing grafts and functional recovery were not observed. Numerous Schwann cells, but not oligodendrocytes, were present within NT-4/5-secreting grafts and remyelinated axons inside the graft. Thus, NT-4/5 and BDNF appear to be interchangeable to elicit substantial axonal growth in the injured spinal cord.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485774     DOI: 10.1016/j.mcn.2004.06.007

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  19 in total

1.  Differential regulation of axon outgrowth and reinnervation by neurotrophin-3 and neurotrophin-4 in the hippocampal formation.

Authors:  Daniel Hechler; Francesco Boato; Robert Nitsch; Sven Hendrix
Journal:  Exp Brain Res       Date:  2010-07-17       Impact factor: 1.972

2.  Diversity of reticulospinal systems in mammals.

Authors:  Marie-Claude Perreault; Andrea Giorgi
Journal:  Curr Opin Physiol       Date:  2019-03-12

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 4.  Growth factors and combinatorial therapies for CNS regeneration.

Authors:  Paul Lu; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

5.  Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury.

Authors:  Hannah M Tuinstra; Misael O Aviles; Seungjin Shin; Samantha J Holland; Marina L Zelivyanskaya; Alan G Fast; Sarah Y Ko; Daniel J Margul; Anne K Bartels; Ryan M Boehler; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Biomaterials       Date:  2011-11-29       Impact factor: 12.479

6.  Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury.

Authors:  Edmund R Hollis; Mark H Tuszynski
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Coiled polymeric growth factor gradients for multi-luminal neural chemotaxis.

Authors:  Nesreen Zoghoul Alsmadi; Lokesh S Patil; Elijah M Hor; Parisa Lofti; Joselito M Razal; Cheng-Jen Chuong; Gordon G Wallace; Mario I Romero-Ortega
Journal:  Brain Res       Date:  2015-03-21       Impact factor: 3.252

Review 8.  Neurotrophic factors in combinatorial approaches for spinal cord regeneration.

Authors:  Julianne McCall; Norbert Weidner; Armin Blesch
Journal:  Cell Tissue Res       Date:  2012-04-12       Impact factor: 5.249

Review 9.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

10.  Endogenous TrkB ligands suppress functional mechanosensory plasticity in the deafferented spinal cord.

Authors:  Leanne M Ramer; Lowell T McPhail; Jaimie F Borisoff; Lesley J J Soril; Timothy K Y Kaan; Jae H T Lee; James W T Saunders; Lucy P R Hwi; Matt S Ramer
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.